These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24739366)

  • 1. MicroRNAs as biomarkers in pituitary tumors.
    Di Ieva A; Butz H; Niamah M; Rotondo F; De Rosa S; Sav A; Yousef GM; Kovacs K; Cusimano MD
    Neurosurgery; 2014 Aug; 75(2):181-9; discussion 188-9. PubMed ID: 24739366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.
    Lindner K; Haier J; Wang Z; Watson DI; Hussey DJ; Hummel R
    Clin Sci (Lond); 2015 Jan; 128(1):1-15. PubMed ID: 25168167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
    Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
    J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis-related microRNAs in esophageal cancer.
    Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
    Expert Opin Biol Ther; 2014 Apr; 14(4):483-9. PubMed ID: 24506707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of miRNAs in the pathogenesis of pituitary adenomas].
    Németh K; Darvasi O; Szücs N; Czirják S; Butz H
    Orv Hetil; 2018 Feb; 159(7):252-259. PubMed ID: 29429349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of microRNA in oncogenesis of pituitary tumors and their practical significance].
    Lapshina AM; Khandaeva PM; Belaya ZE; Rozhinskaya LY; Melnichenko GA
    Ter Arkh; 2016; 88(8):115-120. PubMed ID: 28635944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
    Schwarzenbach H
    Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to use microRNAs as therapeutic targets.
    Gentilin E; Degli Uberti E; Zatelli MC
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):629-639. PubMed ID: 27923456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?
    Nair N; Gupta S; Collier IX; Gongora E; Vijayaraghavan K
    Int J Cardiol; 2014 Aug; 175(3):395-9. PubMed ID: 25002320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
    Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
    Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
    Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in pituitary tumors.
    Wierinckx A; Roche M; Legras-Lachuer C; Trouillas J; Raverot G; Lachuer J
    Mol Cell Endocrinol; 2017 Nov; 456():51-61. PubMed ID: 28089822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of miRNAs as biomarkers for multiple myeloma.
    Rocci A; Hofmeister CC; Pichiorri F
    Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in the human pituitary.
    Sivapragasam M; Rotondo F; Lloyd RV; Scheithauer BW; Cusimano M; Syro LV; Kovacs K
    Endocr Pathol; 2011 Sep; 22(3):134-43. PubMed ID: 21647843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.